Combination of Bevacizumab and Continuation of EGFR-TKIs in NSCLC Patients beyond Gradual ProgressionZ. Xu,F. Teng,X. Hao, Q. Wang,J. Li,P. XingJOURNAL OF THORACIC ONCOLOGY（2022）引用 0|浏览3暂无评分关键词EGFR-TKI, bevacizumab, gradual progressionAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
